SHIBATA Hiroyuki

写真a

Affiliation

Graduate School of Medicine  Doctorial Course in Medicine  Oncoregulatory Medicine  Department of Clinical Oncology

Date of Birth

1962

Laboratory Address

Hondo 1-1-1, Akita

Laboratory Phone number

+81-18-884-6261

Laboratory Fax number

+81-18-884-6455

Mail Address

E-mail address

Research Fields, Keywords

Medical Oncology, Molecular Oncology

Graduating School 【 display / non-display

  •  
    -
    1987.03

    Tohoku University   Faculty of Medicine   Graduated

Graduate School 【 display / non-display

  •  
    -
    1991.03

    Tohoku University  Graduate School,Division of Medicine  Doctor's Course  Completed

Campus Career 【 display / non-display

  • 2009.04
    -
    Now

    Akita University   Graduate School of Medicine   Doctorial Course in Medicine   Oncoregulatory Medicine   Department of Clinical Oncology   Professor  

Research Field (grants-in-aid-for-scientific-research classification) 【 display / non-display

  • General internal medicine (including psychosomatic medicine)

 

Thesis for a degree 【 display / non-display

  • Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation

    Shibata H, Kanamaru R, Sato T, Ishioka C, Konishi Y, Ishikawa A, Wakui A, Tsuruo T 

    Jpn J Cancer Res.    1991.03

    Domestic Co-author

Published Papers 【 display / non-display

  • Cohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome.

    Inoue M, Shoji M, Shindo N, Otsuka K, Miura M, Shibata H.

    BMC Pharmacology & Toxicology     2015.03  [Refereed]

    Domestic Co-author

  • Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo.

    Uehara Y, Inoue M, Fukuda K, Yamakoshi H, Hoshi Y, Kanda H, Oshima M, Iwabuchi Y, Shibata H.

    Gastric Cancer     2014.10  [Refereed]

    Domestic Co-author

  • Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer.

    Imai H, Soeda H, Komine K, Otsuka K, Shibata H.

    BMC Palliative Care     2013.10  [Refereed]

    Domestic Co-author

  • Utility of Measuring Circulating Tumor Cell Counts to Assess the Efficacy of Treatment for Carcinomas of Unknown Primary Origin.

    Komine K, Inoue M, Otsuka K, Fukuda K, Nanjo H, Shibata H.

    ANTICANCER RESEARCH     2013.06  [Refereed]

    Domestic Co-author

  • A Phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.

    Kanai M, Otsuka K, SatoM, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H.

    Cancer Chemotherapy and Pharmacology   71 ( 6 ) 1521 - 1530   2013.03  [Refereed]

    Domestic Co-author

display all >>